146 related articles for article (PubMed ID: 15534853)
1. The role of fetal hemoglobin-enhancing agents in thalassemia.
Lal A; Vichinsky E
Semin Hematol; 2004 Oct; 41(4 Suppl 6):17-22. PubMed ID: 15534853
[TBL] [Abstract][Full Text] [Related]
2. Clinical studies with fetal hemoglobin-enhancing agents in sickle cell disease.
Saunthararajah Y; DeSimone J
Semin Hematol; 2004 Oct; 41(4 Suppl 6):11-6. PubMed ID: 15534852
[TBL] [Abstract][Full Text] [Related]
3. Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease.
Saunthararajah Y; Hillery CA; Lavelle D; Molokie R; Dorn L; Bressler L; Gavazova S; Chen YH; Hoffman R; DeSimone J
Blood; 2003 Dec; 102(12):3865-70. PubMed ID: 12907443
[TBL] [Abstract][Full Text] [Related]
4. Maintenance of elevated fetal hemoglobin levels by decitabine during dose interval treatment of sickle cell anemia.
DeSimone J; Koshy M; Dorn L; Lavelle D; Bressler L; Molokie R; Talischy N
Blood; 2002 Jun; 99(11):3905-8. PubMed ID: 12010787
[TBL] [Abstract][Full Text] [Related]
5. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
Koshy M; Dorn L; Bressler L; Molokie R; Lavelle D; Talischy N; Hoffman R; van Overveld W; DeSimone J
Blood; 2000 Oct; 96(7):2379-84. PubMed ID: 11001887
[TBL] [Abstract][Full Text] [Related]
6. Induction of hemoglobin F synthesis in patients with beta thalassemia.
Ley TJ; Nienhuis AW
Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.
Atweh GF; Schechter AN
Curr Opin Hematol; 2001 Mar; 8(2):123-30. PubMed ID: 11224687
[TBL] [Abstract][Full Text] [Related]
8. DNA hypo-methylating agents and sickle cell disease.
Saunthararajah Y; Lavelle D; DeSimone J
Br J Haematol; 2004 Sep; 126(5):629-36. PubMed ID: 15327513
[TBL] [Abstract][Full Text] [Related]
9. Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
Molokie R; Lavelle D; Gowhari M; Pacini M; Krauz L; Hassan J; Ibanez V; Ruiz MA; Ng KP; Woost P; Radivoyevitch T; Pacelli D; Fada S; Rump M; Hsieh M; Tisdale JF; Jacobberger J; Phelps M; Engel JD; Saraf S; Hsu LL; Gordeuk V; DeSimone J; Saunthararajah Y
PLoS Med; 2017 Sep; 14(9):e1002382. PubMed ID: 28880867
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobinopathies.
Atweh GF; DeSimone J; Saunthararajah Y; Fathallah H; Weinberg RS; Nagel RL; Fabry ME; Adams RJ
Hematology Am Soc Hematol Educ Program; 2003; ():14-39. PubMed ID: 14633775
[TBL] [Abstract][Full Text] [Related]
11. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
Fathallah H; Atweh GF
Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
[TBL] [Abstract][Full Text] [Related]
12. Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia.
Breda L; Rivella S; Zuccato C; Gambari R
Expert Rev Hematol; 2013 Jun; 6(3):255-64. PubMed ID: 23782080
[TBL] [Abstract][Full Text] [Related]
13. Therapies to increase fetal hemoglobin in sickle cell disease.
Steinberg MH
Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
[TBL] [Abstract][Full Text] [Related]
14. 5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.
Ley TJ; DeSimone J; Noguchi CT; Turner PH; Schechter AN; Heller P; Nienhuis AW
Blood; 1983 Aug; 62(2):370-80. PubMed ID: 6191799
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience with fetal hemoglobin induction therapy in patients with β-thalassemia.
Musallam KM; Taher AT; Cappellini MD; Sankaran VG
Blood; 2013 Mar; 121(12):2199-212; quiz 2372. PubMed ID: 23315167
[TBL] [Abstract][Full Text] [Related]
16. Induction of fetal hemoglobin in the treatment of sickle cell disease.
Fathallah H; Atweh GF
Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
[TBL] [Abstract][Full Text] [Related]
17. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
Dover GJ; Charache S; Nora R; Boyer SH
Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
[No Abstract] [Full Text] [Related]
18. Pharmacological induction of fetal hemoglobin in sickle cell disease and beta-thalassemia.
Atweh GF; Loukopoulos D
Semin Hematol; 2001 Oct; 38(4):367-73. PubMed ID: 11605172
[TBL] [Abstract][Full Text] [Related]
19. 5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
Humphries RK; Dover G; Young NS; Moore JG; Charache S; Ley T; Nienhuis AW
J Clin Invest; 1985 Feb; 75(2):547-57. PubMed ID: 2579100
[TBL] [Abstract][Full Text] [Related]
20. Fetal globin gene inducers: novel agents and new potential.
Perrine SP; Castaneda SA; Chui DH; Faller DV; Berenson RJ; Siritanaratku N; Fucharoen S
Ann N Y Acad Sci; 2010 Aug; 1202():158-64. PubMed ID: 20712788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
